MAB.WA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$28M	-10.0%	$-2.00	$-2.00–$-2.00	—	1
2027	$52M	+85.7%	$-0.30	$-0.30–$-0.30	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
MAB.WAMabion S.A.	$7.91	-1.13%	$128M	—
AWM.WAAirway Medix S.A.	$0.28	-0.36%	$32M	—
CTX.WACaptor Therapeutics Spolka Akcyjna	$72.50	+0.28%	$459M	—
GMT.WAGenomtec S.A.	$3.61	+0.00%	$62M	—
ICE.WAMedinice S.A.	$57.40	-4.17%	$533M	—
MOC.WAMolecure S.A.	$7.63	+3.39%	$189M	—
NNG.WANanoGroup S.A.	$2.42	-1.83%	$103M	—

Source: Financial Modeling Prep · peers by sector/industry

Mabion S.A.

Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.

www.mabion.eu

Employees: 202
IPO / List date: Aug 10, 2010
HQ: PL

Held by traders on TradeandTell

No one on the platform currently holds MAB.WA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in MAB.WA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded MAB.WA yet.